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Phenylephrine, a common 
cold remedy active ingredient, 
suppresses uterine contractions 
through cAMP signalling
Xingjuan Chen1, Marya Meroueh1, Gabriela Mazur1, Evan Rouse1,2, Karmjot Singh Hundal1, 
Christopher W. Stamatkin1,3 & Alexander G. Obukhov  1
Regulation of uterine contractility is an important aspect of women’s health. Phenylephrine, a 
selective agonist of the α1-adrenoceptor and a potent smooth muscle constrictor, is widely used in 
women even during pregnancy to relieve cold-related symptoms, to treat postpartum haemorrhoid, 
and during routine eye exams. We performed isometric tension recordings to investigate the effect of 
phenylephrine on mouse uterine contractility. Phenylephrine decreased spontaneous and oxytocin-
induced contractions in non-pregnant mouse uterine rings and strips with an IC50 of ~1 μM. Prazosin, 
an inhibitor of α1-adrenoceptor, did not prevent phenylephrine-mediated relaxations. Conversely, 
ICI118551, an antagonist of β2-adrenoceptors, inhibited phenylephrine relaxation. In the presence 
of ICI118551, high concentrations (>30 μM) of phenylephrine caused mouse uterine contractions, 
suggesting that β-adrenoceptor-mediated inhibition interferes with the phenylephrine contractile 
potential. Phenylephrine-dependent relaxation was reduced in the uterus of pregnant mice. We 
used primary mouse and human uterine smooth muscle cells (M/HUSMC) to establish the underlying 
mechanisms. Phenylephrine stimulated large increases in intracellular cAMP in M/HUSMCs. These cAMP 
transients were decreased when HUSMCs were cultured in the presence of oestrogen and progesterone 
to mimic the pregnancy milieu. Thus, phenylephrine is a strong relaxant in the non-pregnant mouse 
uterus, but exhibits diminished effect in the pregnant uterus.
Excessive uterine contractility is strongly associated with primary dysmenorrhea (menstrual pain/cramps) in 
young women1,2 and preterm labour in pregnant women3–6. Primary dysmenorrhea requiring medications to 
reduce pain occurs in up to 55% of young women7; and preterm labour complicates up to 10% of pregnancies8. 
Over-the-counter cold-flu medications are extensively used in women, particular phenylephrine formulations. 
Although phenylephrine is a potent smooth muscle constrictor, little work has been done to explore its effect on 
uterine contractility.
Phenylephrine is clinically used to treat hypotension as a vasoconstrictor. Phenylephrine is also one of the 
most widely consumed over-the-counter remedies with a broad range of therapeutic uses. Indicated for nasal 
decongestion, phenylephrine is a key active ingredient in several cold-relieving formulations, such as Vicks 
Dayquil Cold & Flu Relief, Theraflu Multi-Symptom Severe Cold, Robitussin Peak Cold Daytime Cold + Flu and 
others, which are taken by millions of pregnant and non-pregnant women. The nasal decongesting effect is attrib-
uted to phenylephrine’s potential of constricting vascular smooth muscle. Topical phenylephrine is widely used 
to treat postpartum haemorrhoids in women9,10. Its ophthalmic formulation is used to constrict the iris dilator 
smooth muscles, which causes pupil dilation allowing visualization of the retina during routine eye exams. It has 
been demonstrated that intranasal, ophthalmic, or oral administration of phenylephrine may result in its systemic 
concentration surge within the micromolar range11,12.
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Phenylephrine is an agonist of the α1-adrenergic receptor, which is believed to have practically no β-adrenergic 
activity13. The α1-adrenergic receptor is a Gq/11 protein-coupled receptor. Upon activation of the α1-adrenergic 
receptor, the heterotrimeric G protein, Gq/11, dissociates to release α and βγ subunits, which in turn activate 
phospholipase C (PLC) inducing the phosphoinositide signalling cascade. PLC activation leads to an increase in 
intracellular IP3 that binds to the IP3 receptor on the endoplasmic reticulum to cause calcium release from intra-
cellular stores, followed by calcium influx, eventually triggering smooth muscle contraction.
Uterine smooth muscles express both α and β adrenoceptors14–17. α adrenoceptor activation increases uterine 
contractility15,16. Conversely, agonists of β2 adrenoceptors cause a potent relaxation and are clinically used to 
prevent preterm labor18. The expression level of adrenoceptors is altered in the pregnant uterus15,16.
We performed isometric tension measurements in mouse uterine rings to investigate the effects of phenyle-
phrine on uterine contractility. Primary uterine smooth muscle cells were used to investigate the molecular mech-
anisms underlying the compound action. Surprisingly, our data revealed that phenylephrine has a potent relaxant 
effect in the non-pregnant uterus at clinically-relevant concentrations.
Results
Phenylephrine inhibits spontaneous and oxytocin-induced contractions of the mouse uterus. 
Phenylephrine is a known smooth muscle constrictor and is clinically used to treat hypotension19. We first 
employed the isometric tension measurement approach to test whether phenylephrine increases the contractil-
ity of the non-pregnant mouse uterus. The uterine rings exhibited regular, spontaneous activity when 0.1–0.5 g 
preload was given (Fig. 1a). Unexpectedly, phenylephrine significantly decreased the frequency and amplitude 
of contractions when it was used at a concentration between 0.01–10 µM in mouse uterine rings with sponta-
neous activity (Fig. 1a). The right inset in Fig. 1a shows the concentration-dependent inhibition curve for phe-
nylephrine. The apparent EC50 value for phenylephrine was 1.1 ± 0.7 µM (N = 8). As shown in Fig. 1b, 100 nM 
Figure 1. Phenylephrine inhibits the spontaneous and oxytocin-induced contractions in mouse uterus.  
(a) A sample trace shows the effect of phenylephrine (PE) on spontaneous contractility in a mouse uterine ring. 
The left inset shows a photograph of isolated mouse uterine horns and vagina. Yellow rectangles show the two 
segments of uterine horns typically used for isometric tension experiments. The dose-response curve for PE-
induced relaxation is shown in the right inset (N = 8, the data were presented as mean ± S.E.). (b) A sample 
trace depicts that PE inhibits oxytocin-induced contractions in the mouse uterine ring in a concentration-
dependent manner. The corresponding dose-response curve is shown in the inset (N = 6). (c) A sample trace 
shows the effect of 1 μM phenylephrine (PE) on a uterine ring isolated from CO2-anesthesized female mouse 
(N = 4). (d,e) Summary data for the frequency and amplitude of spontaneous contractions in uterine rings 
isolated from CO2-anesthesized female mice (N = 4). (f–k) Shown are sample traces and summary data for the 
effect of 1 μM phenylephrine (PE) on the frequency and amplitude of spontaneous and oxytocin (100 nM)-
induced contractility in uterine strips from CO2-anesthesized female mice (N = 4). Active tension changes are 
shown in (a–c,f,g). The data were presented as means ± S.E. The value of “N” is the number of mice. The vertical 
arrows show the times where the drugs were added to the bath. OXT = oxytocin (100 nM).
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oxytocin, which is clinically used to induce labour, potently stimulated the uterus contractions. Phenylephrine 
dose-dependently inhibited oxytocin-induced contractions with an apparent EC50 value of 0.3 ± 0.2 µM (N = 6). 
In these experiments, we used isoflurane anaesthesia when mice were euthanized. To ensure that isoflurane 
anaesthesia is not responsible for the lack of phenylephrine-induced contractions, we investigated whether phe-
nylephrine would constrict uterine rings and strips obtained from the mice euthanized under CO2 inhalation 
anaesthesia. We found that phenylephrine still caused potent relaxation in the uterine rings and strips obtained 
from mice, which were never exposed to isoflurane (Fig. 1c,f,g). Bar graphs in Fig. 1d,e,h–k show that phenyle-
phrine significantly decreased both the peak amplitude and frequency of uterine contractions in both rings and 
strips, representing the activity of circular and longitudinal smooth muscle fibres, respectively.
Phenylephrine inhibits uterine contractions by activating the β2-adrenoceptor. After confirm-
ing that phenylephrine is a potent relaxant in the mouse uterus, we set out to investigate the mechanism of 
phenylephrine’s relaxant effect. Phenylephrine is a known agonist of the α1-adrenergic receptor. Therefore, we 
first tested whether its relaxant effect depends on the activation of the α1-adrenergic receptor by using pra-
zozin, an antagonist of the α1-adrenergic receptor. 1 µM prazosin did not abolish the phenylephrine-induced 
relaxation of non-pregnant mouse uterine rings and strips in the presence (Fig. 2a,c,d,h and i) or absence of 
oxytocin (Fig. 3b,d and f). We next tested ICI118551, a β2-adrenergic receptor antagonist20. Pretreatment with 
1 µM ICI118551 prevented the phenylephrine-induced inhibition in both spontaneously contracting uterine rings 
and strips (Fig. 2b,c,f,h and i) and oxytocin-stimulated uterine rings and strips (Fig. 3c–e). The data in Fig. 2c 
(N = 5), 2h (N = 4), and 2i (N = 4) and Fig. 3d (N = 8) showed that 1 µM ICI118551 significantly blocked the 
1, 3, and 10 µM phenylephrine-induced relaxations, compared to the vehicle control (DMSO). DMSO did not 
affect phenylephrine-induced relaxations (Fig. 2c,e,g,h and i). Comparison of prazosin and ICI118551 effects 
on phenylephrine-induced relaxations in oxytocin-stimulated uterine strips is shown in Fig. 3g,h (N = 4). 
Figure 2d,e (N = 4) and Fig. 3f (N = 4) show that acute application of 1 µM ICI118551 potently reversed the 10 µM 
phenylephrine-induced relaxation in uterine strips. We noticed that phenylephrine increased uterine contractility 
at much higher concentrations (>30 µM) in the presence of 1 µM ICI118551 (Fig. 2b) likely due to its activation 
Figure 2. β2-adrenoceptor antagonist prevents the PE induced relaxation of spontaneous uterine contractions. 
(a) A sample trace shows that prazosin has no effect on PE-induced inhibition of spontaneous contractility in 
a mouse uterine ring. (b) A sample trace shows that ICI118551, a β2-adrenoceptor antagonist, prevents the 
inhibition induced by PE in a mouse uterine ring. (c) Summary for the date shown in (a,b). DMSO (N = 5) 
vs ICI118551 (N = 5), *p < 0.05, **p < 0.01; ICI118,551 vs Prazosin (N = 5), #p < 0.05, ##p < 0.01. (d–g) The 
sample traces show that ICI118551 prevents the inhibition induced by PE in the mouse uterine strips, whereas 
prazosin has no effect on the PE-induced inhibition of the spontaneous contractility’s frequency and amplitude. 
(h,i) Summary for the data shown in (d–g). DMSO (N = 4) vs ICI118551 (N = 4), *p < 0.05, **p < 0.01; 
ICI118551 vs Prazosin (N = 4), #p < 0.05, ##p < 0.01. The data were presented as means ± S.E. The value of “N” 
is the number of mice. Active tension changes are shown in (a,b and d–g).
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of the α1-adrenergic receptor. Thus, we concluded that relaxant effect of phenylephrine is mediated via activation 
of the β2 adrenergic receptor on uterine smooth muscle cells.
Phenylephrine increased the intracellular cAMP levels in isolated mouse uterine smooth muscle 
cells. The results of isometric tension experiments suggested that phenylephrine inhibited uterine con-
tractions through activation of the β2 adrenergic receptor. Activation of the β adrenergic receptor leads to 
GS-heterotrimeric protein dissociation and consequent stimulation of adenylyl cyclase that produces 3′,5′-cyclic 
adenosine monophosphate (cAMP). Therefore, we then tested if phenylephrine modulates intracellular cAMP 
Figure 3. β2-adrenoceptor antagonist prevented the PE-induced relaxation of the uterus in presence of 
oxytocin. (a–c) Sample traces show that ICI118551, a β2-adrenoceptor antagonist, prevents the inhibition 
induced by PE in the mouse uterine rings, whereas prazosin has no effect on the PE-induced inhibition of 
oxytocin-induced contractions. (d) Concentration-inhibition relationships for the data shown in (a,b). DMSO 
(N = 3) vs ICI118551 (n = 8), *p < 0.05, **p < 0.01; ICI118551 vs Prazosin (N = 8), #p < 0.05, ##p < 0.01. 
(e,f) Sample traces show that ICI118551 prevents the inhibition induced by PE in the mouse uterine strips, 
whereas prazosin has no effect on the PE-induced inhibition of oxytocin-induced contractions’ frequency 
and amplitude. (g,h) Concentration-inhibition relationships for the data shown in (e,f). ICI118551 (N = 4) vs 
Prazosin (N = 4), #p < 0.05, ##p < 0.01. The data were presented as means ± S.E. The value of “N” is the number 
of mice. Active tension changes are shown in (a–c,e and f).
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levels in uterine smooth muscle cells. In these experiments, we utilized a fluorescent cAMP-reporter assay. The 
cAMP reporter construct was transduced into uterine smooth muscle cells using a baculovirus-based delivery 
system. Phenylephrine (10 µM) increased the cytoplasmic cAMP concentration (n = 136, Fig. 4a,b), although the 
amount of cAMP production was smaller than that induced by isoproterenol (Iso, 10 µM), a positive control. The 
application of oxytocin did not affect phenylephrine-induced intracellular cAMP increases (n = 28, Fig. 4e,f). 
Notably, phenylephrine not only increased cAMP levels, but the drug also slightly reduced oxytocin-induced 
calcium increases (n = 216, Fig. 4c,d).
We next texted the effect of ICI118551 (1 µM) on the phenylephrine induced cAMP transients in mouse uter-
ine smooth muscle cells. As shown in Fig. 4g–i, phenylephrine (10 µM) failed to increase the intracellular cAMP 
in the ICI118551 (1 µM)-pretreated uterine smooth muscle cells (n = 77), whereas the cells pre-treated with 
Figure 4. Phenylephrine stimulated the intracellular increase of cAMP levels in isolated mouse uterus smooth 
muscle cells. (a–d) The time courses show the changes of Fura-2 fluorescence ratio (F345/F380, black line) and 
cAMP reporter fluorescence intensity ratio (F570/F480, red line) on isolated mouse uterus smooth muscle cells 
transduced with the cAMP reporter construct. (b,d) Show the summary data from (a, n = 136) and (b, n = 216). 
The fluorescence values were normalized to the baseline fluorescence level. To detect intracellular cAMP 
change, the Red Upward cADDis cAMP sensor was excited at 570 nm, whereas Green Downward cADDis 
cAMP sensor fluorescence was excited at 480 nm. Bars indicate the times when the applications of compounds 
took place. The data set is obtained from three to six repeats of independent experiments performed on 
different days. (e) The time course shows the cAMP reporter fluorescence intensity ratio (red line) changes in 
isolated mouse uterus smooth muscle cells infected with the cAMP reporter construct. (f) Summary for the 
data shown in (e, n = 28). The data set is obtained from four independent experiments. (g–i) The time courses 
and summary data show that ICI118551 (n = 77), but not the vehicle DMSO (n = 51) prevents the PE-induced 
changes of cAMP reporter fluorescence intensity ratio (F570/F480) in isolated mouse uterine smooth muscle 
cells transduced with the cAMP reporter construct. The inset in (g) shows the time course of KCl-induced 
ΔF340/F380 ratio changes (black line). (j–l) The siRNA against the β2-adrenoceptor, but not the Negative 
Control #1 siRNA, prevented phenylephrine-induced cAMP rises in mouse uterine smooth muscle cells. (k) 
Shows the time courses for PE- and Iso-induced changes in cAMP levels in mouse uterine smooth muscle cells 
electroporated with the indicated siRNAs. PE failed to stimulate cAMP rises in mouse uterine smooth muscle 
cells electroporated with siRNA against the β2-adrenoceptor (n = 101), but induced cAMP rises in mouse 
uterine smooth muscle cells electroporated with Negative Control #1 siRNA (n = 91). PE, phenylephrine; Oxt, 
oxytocin; Iso, isoproterenol. **p < 0.01, ****p < 0.0001. The data were presented as means ± S.E. The grey 
vertical lines represent S.E. The “n” values indicate the number of cells, and each data set is obtained from three 
experiments.
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DMSO (n = 51) had normal cAMP responses to phenylephrine (10 µM). We found that the effect of ICI118551 
was not reversible even after the cells were washed for several minutes with the standard Krebs solution. Similar 
observations were made during the isometric tension experiments in mouse uterine rings and strips.
To further verify the role of β2 adrenergic receptor in mediating phenylephrine-induced cAMP rises in mouse 
uterine smooth muscle cells, we utilized the siRNA approach. The siRNA targeting the β2 adrenergic receptor 
(siRNA-Adrb2) or Negative control (scrambled) siRNA was electroporated into mouse uterine smooth muscle 
cells. We found that siRNA-Adrb2-electroporated cells (n = 101) had a significantly smaller responses to phe-
nylephrine compared to the negative control #1 siRNA-electroporated cells (n = 91, Fig. 4k,i). These data indicate 
that β2-adrenoceptor-dependent increases in the intracellular cAMP underlies phenylephrine relaxant effects on 
spontaneous and oxytocin-induced contractions in the mouse uterus.
Caffeine decreases spontaneous and oxytocin-induced contractions in the mouse uterus. 
Caffeine was also reported to decrease the uterine contractility through inhibiting the activity of phosphodi-
esterase and then increasing cAMP21. We confirmed that 10 mM caffeine did increase intracellular cAMP levels 
(Fig. 5e,f) and significantly relaxed non-pregnant mouse uterine rings in the presence (N = 9) or absence (N = 5) 
of oxytocin (Fig. 5a,b). The application of IBMX, which inhibits phosphodiesterase reducing cAMP levels, also 
inhibited the spontaneous and oxytocin-stimulated contractility in uterine rings (Fig. 5c,d).
Phenylephrine weakly inhibits the contractions in pregnant mouse uterine rings. We next 
investigated whether phenylephrine caused relaxations of uterine rings from pregnant mice. Phenylephrine 
dose-dependently inhibited the uterine contractions at concentrations ranged from 0.1 to 10 µM. Percent inhi-
bition for phenylephrine in pregnant uterus was significantly smaller at 0.1, 0.3, 1, 3 and 10 µM (Fig. 6a,b, N = 6) 
with an EC50 of 5.1 µM. We also tested the relaxation effects induced by caffeine in uterine rings from pregnant 
mice. As shown in Fig. 6c,d, the pregnant mouse uterine rings had less sensitivity to caffeine. Caffeine at 0.3 and 
1.1 mM induced significantly smaller inhibition in pregnant mouse uterine rings (N = 4).
The effect of phenylephrine on human uterine smooth muscle cells (HUSMCs). We also deter-
mined whether phenylephrine is affecting intracellular cAMP and calcium levels in primary HUSMCs that were 
transduced with the cAMP reporter construct. Oxytocin (100 nM) induced an increase in intracellular calcium 
but had no effect on cAMP levels in HUSMCs (Fig. 7a). Phenylephrine (10 µM, n = 43) and caffeine (10 mM, 
n = 40) increased intracellular cAMP levels in HUSMCs (Fig. 7b–d). Isoproterenol (10 µM) was used as a posi-
tive control in these experiments. We next investigated whether phenylephrine affects stress fibres in HUSMCs 
phalloidin-red, an f-actin marker. Figure 7e shows that the cytoskeletal organization in these treated groups was 
not affected in phenylephrine (n = 17), oxytocin (n = 16) or caffeine (n = 16) treated cells.
The treatment with progesterone (P4) and estradiol-17β (E2) to mimic the pregnancy envi-
ronment decreases the phenylephrine-induced cAMP levels. Since phenylephrine was less effective 
in pregnant mouse uterine rings, we tested whether its effect on cAMP levels would be decreased in HUSMCs 
treated with P4 (1 µM) and E2 (100 nM) for 72 hours. We found that that phenylephrine indeed induced smaller 
cAMP rises in P4/E2-treated HUSMCs (n = 64) as compared to the vehicle control (DMSO)-treated HUSMCs 
(n = 95, Fig. 8a–c). On the other hand, the effect of caffeine on the intracellular cAMP was not different between 
the control and P4/E2 treatment groups. Thus, only the phenylephrine relaxant effect is dependent on the preg-
nancy status in the mouse uterus.
Phenylephrine markedly decreased uterine peristalsis in ex vivo female mouse reproductive 
tract preparations. The uterus constantly exhibits spontaneous wavelike movements (uterine peristalsis). 
Therefore, we next set out to determine whether phenylephrine affects the spontaneous uterine peristalsis in an 
ex vivo female mouse reproductive tract preparation, which included the oviducts, uterine horns, uterine body, 
cervix, and vagina (Fig. 8g). We found that 1 μM phenylephrine potently decreased spontaneous uterine peristal-
sis (N = 5, Fig. 8h; see Supplementary video 1).
Discussion
In this study, we found that phenylephrine potently decreased spontaneous and oxytocin induced contractions 
in the mouse uterus. Interestingly, the relaxant effect of phenylephrine was reduced in pregnant mouse uterus. 
We established that phenylephrine caused intracellular cAMP surges in MUSMCs due to the activation of the β2 
adrenoreceptor, which was likely responsible for phenylephrine’s relaxant action. Phenylephrine-induced cAMP 
increases were also observed in primary HUSMCs, suggesting that phenylephrine may also exhibit tocolytic 
effects in the human uterus. Primary HUSMC cultures pretreated with a combination of P4 and E2 to mimic the 
pregnancy milieu showed reduced phenylephrine-induced cAMP surges, which is consistent with our mouse 
uterus data.
Phenylephrine is an over-the-counter medication, which is routinely used by millions of non-pregnant and 
pregnant women with few safety precautions. The phenylephrine blood plasma concentration may reach a peak 
concentration of 21 μM in a 70 kg healthy woman when a phenylephrine-containing over-the-counter formula-
tion is consumed at recommended doses. Using a mouse uterus model, we established that phenylephrine has a 
significant relaxant effect at 1 μM. Although the relaxant effect was decreased in pregnant mice, 10 µM phenyle-
phrine inhibited 50% of the oxytocin-induced contractility. Thus, the therapeutic doses of phenylephrine may 
modulate uterine contractility.
Exploring the underlying mechanisms of phenylephrine’s relaxant effect in the mouse uterus, we determined 
that phenylephrine acts via the β2-adrenergic receptor rather than the usual α1-adrenergic receptor pathway. 
The β-adrenergic receptor is coupled to the S-type of heterotrimeric G-proteins. Dissociation of GS leads to an 
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Figure 5. Caffeine decreased the uterine contractility by increasing the intracellular cAMP level. (a,b) The time 
courses of active tension changes are shown. Caffeine relaxed the mouse uterine rings in the absence (N = 5) or 
presence (N = 9) of oxytocin. The insets show the extent of caffeine-induced uterine relaxation. (c,d) The sample 
traces of active tension changes show that IBMX, but not DMSO relaxed the mouse uterus rings in absence 
(N = 6) or presence (N = 8) of oxytocin. The bar graphs demonstrate the extent of IBMX-induced uterine 
relaxation. (e,f) The time courses of fluorescence ratio changes. Furo-2 fluorescence changes (intracellular Ca2+ 
changes) are shown as the black line, and cAMP reporter fluorescence ratio changes are depicted as the red line. 
Bar graph (f) shows the summary data for E. Iso, isoproterenol. **p < 0.01, ***p < 0.001, n = 231. The data were 
presented as means ± S.E. The grey vertical lines represent S.E. The “n” values indicate the number of cells. Each 
data set is obtained from three to six repeats of independent experiments performed on different days. The value 
of “N” is the number of mice.
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increased adenylyl cyclase activity and intracellular cAMP surges, which cause smooth muscle relaxation. To 
provide evidence for this mechanism, we used two antagonists, prazosin and ICI118551. Prazosin is an antag-
onist of the α1 receptor. ICI118551 is an antagonist of the β2 receptor. In uterine rings and strips pretreated 
with prazosin, phenylephrine was able to inhibit uterine contractions. Conversely, in uterine rings and strips 
pretreated with ICI118551, the inhibitory effect of phenylephrine was significantly diminished. Though both β2- 
and β3-adrenoceptors are expressed in mouse uterus14,17, the facts that ICI118551 completely prevented phenyle-
phrine relaxations in our mouse uterine preparations and the siRNA against the β2-adrenoceptor was effective 
in decreasing phenylephrine-induced cAMP rises in isolated mouse uterine smooth muscle cells suggest that 
α-adrenoceptors and β3-adrenoceptors are unlikely to be involved. However, additional future studies utilizing 
β2-adrenoceptor knockout mice will be needed to determine whether the β3-adrenoceptor activation might con-
tribute to phenylephrine-mediated relaxant action.
Interestingly, we noticed that phenylephrine increased uterine phasic contractions at the concentrations 
exceeding 30 μM in the presence of ICI118551 most likely due to α1-adrenergic receptor activation. This effect 
was not observed in the absence of the inhibitor. These data suggest that although phenylephrine likely activates 
both α and β-adrenergic receptors in the uterus, the β adrenoceptor activation effect plays a dominant role. Thus, 
it appears that there may be a complex interplay between these two signalling pathways in the uterine smooth 
muscles.
Acting via the β2-adrenoceptor, phenylephrine activates adenylyl cyclase, thereby increasing the intracellular 
concentration of cAMP (Figs 4 and 7). cAMP is known to relax uterine smooth muscles; and it has been proposed 
that the cAMP-induced relaxation involves the activation of cAMP-dependent protein kinase A (PKA), which 
phosphorylates myosin light chain kinase (MYLK)22 and phospholipase C (PLC)23, inhibiting their activity. In 
the present study, we indeed found that phenylephrine not only increased the level of cAMP, but also inhibited 
the oxytocin-induced Ca2+ signalling in primary cultured mouse uterine smooth muscle cells, likely due to the 
cAMP-dependent inhibition of PLC. However, the role of PKA in the cAMP downstream signalling pathway 
remains unclear in the myometrium. It has been recently reported that the exchange protein directly activated by 
cAMP (EPAC) rather than PKA may play the major role in cAMP-induced uterine relaxation24. Further studies 
will be required to better understand the mechanism of cAMP-induced uterine relaxations.
Along with phenylephrine, we investigated the uterine effects of another widely used FDA approved drug, caf-
feine. We established that 2–10 mM caffeine inhibited mouse uterine contractions. In vascular SMCs, caffeine was 
reported to induce a small initial contraction followed by a relaxation. The transient caffeine-induced contraction 
is due to the activation of ryanodine receptors on the sarcoplasmic reticulum25. In our case, we only observe 
Figure 6. Phenylephrine-induced relaxation was less pronounced in pregnant mouse uterine rings. (a,b) A 
sample isometric tension trace and summary data are shown. Phenylephrine (PE) relaxed pregnant mouse 
uterine rings stimulated with oxytocin in a concentration-dependent manner (N = 5). (c,d) A sample trace and 
summary data show the caffeine-mediated inhibition of pregnant uterine ring contractions induced by oxytocin 
(N = 4). *p < 0.05, **p < 0.01, ***p < 0.001. The data were presented as means ± S.E. The value of “N” is the 
number of mice.
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Figure 7. Phenylephrine (PE) and caffeine increased intracellular cAMP levels in HUSMCs. (a–d) Sample 
traces and summary data for phenylephrine (PE, n = 43), oxytocin (Oxt, n = 40), caffeine (n = 28) and 
isoproterenol (Iso)-induced cAMP reporter fluorescence ratio changes in HUSMCs. (e) F-actin stress fiber 
organization visualized with phalloidin-FITC in HUSMCs from control (n = 7), PE (n = 7), oxytocin (n = 6) 
and caffeine (n = 6) treated groups (scale bar indicates 20 µm). The right panel shows the summary data. 
**p < 0.01. The data were presented as means ± S.E. The grey vertical lines represent S.E. The “n” values indicate 
the number of cells. Each data set is obtained from three to five repeats of independent experiments performed 
on different days.
www.nature.com/scientificreports/
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caffeine-induced relaxations in the uterus. It is consistent with a recent report that none of the RyR subtypes 
(RyR1-3) plays a role in the regulation of contractions in mouse myometrial SMCs26.
The relaxant effect of caffeine is likely due to either its direct action on the contractile machinery of uterine 
smooth muscle cells or inhibition of the phosphodiesterase enzyme, which is important for modulating intracel-
lular cAMP levels. Caffeine’s relaxant effect may also be due to the inhibition of the MLC kinase and decreasing 
actin filament binding to the phosphorylated myosin on the actin-myosin interaction27,28. However, our data 
presented in this paper indicate that the inhibition of smooth muscle phosphodiesterase leading to decreased 
intracellular cAMP degradation likely underlies the caffeine-induced relaxation of the mouse uterus.
Figure 8. Effects of phenylephrine in HUSMCs and ex vivo female mouse reproductive tract preparations. 
(a–c) The time course of changes and bar graph show the phenylephrine (PE), oxytocin (Oxt) and isoproterenol 
(Iso)’s effects on the cAMP reporter and Fura-2 fluorescence ratios (DMSO, n = 95; P4/E2, n = 64). 
Phenylephrine induced smaller cAMP transients in the P4 and E2 treated HUSMCs. (d–f) The time course 
and bar graph show caffeine’s effect on the cAMP reporter and Fura-2 fluorescence ratios (DMSO, n = 38; P4/
E2, n = 66). ***p < 0.001. The data were presented as means ± S.E. The grey vertical lines represent S.E. The “n” 
values indicate the number of cells. Each data set is obtained from three repeats of independent experiments 
performed on different days. (g,h) Show two ex vivo female mouse reproductive tract preparations. The sample 
images were consequently acquired with 10 second intervals in either the standard Krebs solution or in Krebs 
solution supplemented with 1 μM phenylephrine. The images were captured from the Supplementary video #1, 
which is available online. Phenylephrine markedly reduced spontaneous uterine horn peristalsis in the ex vivo 
female mouse reproductive tract preparations (N = 5). “o” = oviduct; “v” = vagina; “uh” = uterine horn.
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We determined in this study that the EC50 value for the caffeine relaxant effect on the uterus was about 
0.3 mM. In the victims of acute caffeine overdose, caffeine concentration may reach the range from 0.2 to 2 mM29. 
However, a cup of coffee contains only 80–175 mg of caffeine. Thus, after consuming one cup of coffee, a healthy 
volunteer’s blood plasma caffeine concentration should not exceed 0.01–0.05 mM. Therefore, moderate caffeine 
consumption (less than 200 mg per one sitting) is unlikely to affect uterine contractility.
In healthy non-pregnant women, transvaginal ultrasound and magnetic resonance imaging studies revealed 
the existence of endometrial wavelike movements, also known as uterine peristalsis30–32. Endometrial wave-
like movements are driven by coordinated contractions of myometrial smooth muscles. The direction, inten-
sity, and frequency of the endometrial wavelike movements change throughout the menstrual cycle32,33, with 
cervix-to-fundus uterine contractions dominating during the periovulatory phases. Cervix-to-fundus endome-
trial wavelike movements were also observed in the midfollicular phase, the late follicular phase, and the early 
luteal phase. Fundus-to-cervix endometrial wavelike movements were present in the follicular phase, specifically 
during the earlier follicular phase, assisting menstrual discharge; and opposing waves were observed up to five 
days after ovulation30,32,33. Endometrial wavelike movements may be important to intrauterine sperm transport 
toward the Fallopian tubes and for restricting the embryo implantation to the upper uterine segments32. In vitro 
fertilization studies indicate that impaired endometrial wavelike movements may lead to infertility, ectopic preg-
nancies, miscarriages, and endometriosis33–35. In this study, we observed that 1 μM phenylephrine almost com-
pletely inhibited spontaneous uterine wavelike contractions in mouse ex vivo female mouse reproductive tract 
preparations (Fig. 8g,h; Supplementary video #1, N = 5), suggesting that phenylephrine may potentially interfere 
with fertility. Consistently, mice transiently treated with a β2-adrenoceptor agonist at the time of embryo implan-
tation exhibited the abnormal embryo spacing and increased midterm pregnancy loss17.
In the present paper, we provide evidence that phenylephrine exhibits strong reversible relaxant action in 
non-pregnant mouse uterus by triggering the cAMP signalling machinery, but larger doses of phenylephrine 
are needed to cause 50% inhibition in uterine rings from pregnant mice. Caffeine exerts relaxant actions only 
at non-physiologically high concentrations. Thus, our data suggest that it appears safe to consume moderate 
amounts of caffeinated drinks by healthy pregnant women during labour. But, it is advisable to limit the usage 
of over-the-counter phenylephrine-containing cold/flu remedies during term labour. Phenylephrine-containing 
medications may also need to be avoided in women trying to become pregnant.
Materials and Methods
Animals. All of the animal experiments were approved by the Indiana University School of Medicine 
Institutional Animal Care and Use Committee and strictly adhered to the guidelines described in the Guide for 
the Care and Use of Laboratory Animals published by the United States National Institutes of Health. 2–4 month 
old C57BL/6 mice were used in the study. The sexually mature mice were anesthetized using brief inhalation 
of isoflurane and euthanized by decapitation. The oestrous cycle stage was determined by examining cellular 
content from a vaginal douche as described elsewhere36. The uteri were isolated, cleaned from the surrounding 
connective tissue and cut into 3 mm length rings from the middle sections of the uterine horns (inset of Fig. 1a). 
Some uterine horns were cut-open longitudinally and used as tissue strips in the isometric tension experiments. 
Before the isometric tension recordings, the rings and strips were allowed to equilibrate for at least 1–2 hours in 
the oxygenated Krebs solution at 37 °C after multiple washes with the Krebs solution. In a subset of experiments, 
the mice were anesthetized by inhalation of 5% CO2 followed by euthanasia with decapitation to demonstrate that 
isoflurane did not affect the outcome of the phenylephrine experiments.
Isometric tension experiments. The uterine rings were mounted on the wires of a wire myograph and 
lowered into 6 ml tissue baths that were filled with a standard Krebs buffer maintained at 37 °C. The buffer was 
continuously oxygenated with a gas mixture of 95% O2 and 5% CO2. The optimum length was determined 
as described elsewhere37–40. All drugs were added directly to the tissue baths while the contraction force was 
recorded.
Ex vivo mouse uterine peristalsis assay. The entire intact female mouse reproductive tract, including 
the oviducts, uterine horns, uterine body, cervix, and vagina, was isolated and placed in a Petri dish filled with the 
oxygenated Krebs buffer. The tissue preparation was maintained at room temperature. The uterine peristalsis in 
the absence or presence of 1 μM phenylephrine was documented by digital video recording in MP4 video format 
using a Cannon EOS Rebel T6i camera.
Cell culture. The isolated uterine horns were cut open longitudinally and were washed using DPBS. The endo-
metrial layer was removed using microscissors and discarded, whereas the myometrium was minced. The tissue 
pieces of myometrium were dissociated in Hank’s Balanced Salt medium containing collagenase P (1 mg/mL, 
from Clostridium histolyticum, Roche, Indianapolis, IN, USA), 0.2 mM CaCl2, 0.125% bovine serum albumin 
(BSA) for 40 min, 37 °C. After collagenase treatment, the digested tissue pieces were gently triturated to disperse 
single smooth muscle cells. The obtained cells were washed with DPBS (3×) and then plated on glass coverslips. 
The cells were cultured in Eagle’s Minimum Essential Medium (EMEM, cat. No. 30-2003, ATCC, Manassas, VA, 
USA) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 U/mL streptomycin for 24–48 h 
in the 5% CO2 incubator at 37 °C before the experiments. The human uterine smooth muscle cells (HUSMCs) 
were obtained from Lonza (CLONETICS Uterine Smooth Muscle Cell Systems, CC-2562) and cultured in the 
Lonza-recommended medium SmBM (Lonza,catlog No: cc-3181) supplemented with SmGM-2 SingleQuots (cat. 
No: cc-4149) in the 5% CO2 incubator at 37 °C.
Solutions. The standard Krebs buffer contained (in mM): 130 NaCl, 5 KCl, 2 CaCl2, 1.2 NaH2PO4, 0.56 
MgCl2, 25 NaHCO3, and 5 glucose. The 70 mM KCl solution contained (in mM): 65 NaCl, 70 KCl, 2 CaCl2, 1.2 
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NaH2PO4, 0.56 MgCl2, 25 NaHCO3, and 5 glucose. The extracellular solution for fluorescence imaging contained 
(in mM): 145 NaCl, 2.5 KCl, 2. CaCl2, 1 MgCl2, 10 HEPES, and 5.5 glucose (pH 7.2 adjusted with NaOH).
cAMP reporter assay in live cells. The cyclic AMP (cAMP) reporter assay was purchased from Montana 
Molecular (Bozeman, MT, USA) and was performed as recommended by the manufacturer. The isolated M/
HUSMCs were plated and grown for 24 h in culture medium supplemented with 10% fetal bovine serum or 
SmBM supplemented with SmGM-2 SingleQuots. The transduction reaction (25 µl Green Downward cADDis 
cAMP sensor, 20 µl Red Upward cADDis cAMP sensor and 4 µl 500 mM Sodium Butyrate per 1 ml complete 
medium) were added to the cells. The cells were incubated under normal growth conditions (5% CO2 and 37 °C) 
while being protected from light for 6 h. Then, the transduction solution was removed and 2 ml complete medium 
with sodium butyrate (2 mM) was added. Cells were incubated for an additional period of 24 h. Before measuring 
fluorescence, the culture medium was replaced with DPBS.
Fluorescence imaging. The cultured uterine smooth muscle cells were incubated in Ca2+/Mg2+-containing 
PBS, supplemented with 4 μM Fura-2AM for an hour, and then incubated for another 30 min in PBS containing 
no Fura-2AM. A Till-Photonics single-cell fluorescence imaging system was used to monitor intracellular Ca2+ 
changes in isolated Fura-2-loaded M/HUSMCs. The fluorescence data are presented after subtracting the back-
ground fluorescence. The cultured cells were continuously superfused with the test solutions at a rate of 1.5 mL/min. 
The cells were depolarized with high external potassium solution (140 mM KCl, Fig. 4g) and only those cells that 
showed calcium increases in high potassium solution were used for analysis.
siRNA assay. Silencer®Select siRNA against the β2-adrenoceptor (siRNA-Adrb2) and Silencer®Select 
Negative Control No. 1 siRNA were purchased from Ambion (Life Technology Corporation, Carlsbad, CA, USA; 
Cat. No. s62080 and 4390843, respectively). 25 pmol of β2-adrenoceptor or Negative Control siRNAs were added 
to the separate suspensions of freshly isolated mouse smooth muscle cells (~1 million cells in 100 μl AoSMC 
Nucleofector® Solution). The cell suspension combined with siRNA was transferred in a Nucleofector cuvette, 
which was then inserted into the Cuvette Holder of Amaxa’s Nucleofector II Device and Nucleofector Program 
U-025 was applied. The electroporated cells were added to 500 µl of EMEM supplemented with 10% fetal bovine 
serum and plated on glass coverslips. About 12 h later, the cells were transduced with the cAMP reporter plasmids 
and were cultured as described above for an additional 48 h period before beginning the fluorescence imaging 
experiments.
Statistical analyses. The data were presented as mean ± standard error (S.E.) and analysed by the Sigma 
Plot12. The unpaired t test or Mann-Whitney Rank Sum Test was used to determine the significant different 
between two groups data with normally distributed populations and equal variances or non-normally distributed 
populations with different variances. When the two data sets were obtained from before and after application 
experiments with or without normally distributed populations with equal variances, the paired t test or Wilcoxon 
Signed Rank Test was used to determine whether there is a statistically significant difference. The one-way 
ANOVA test or the Kruskal-Wallis ANOVA on Ranks test followed by a post hoc all pairwise multiple compar-
ison test was used to determine whether there is a statistically significant difference between multiple groups 
presenting normally distributed populations with equal variances or not. The Two Way ANOVA test followed by 
the Student-Newman-Keuls post hoc all pairwise multiple comparison test was uses to compare the experimental 
groups affected by two different factors when the data sets were normally distributed populations with equal vari-
ances. The data sets were considered significantly different if the p value was < 0.05. Throughout the paper, the “n” 
values indicate the number of tested cells; and the values of “N” are the number of used mice. During the analysis 
of the data obtained with cell cultures, the smooth muscle cells were functionally identified using applications of 
140 mM KCl (Fig. 4g, inset). Only smooth muscle cells express voltage-gated calcium channels and show calcium 
influx upon depolarization with the 140 mM KCl solution. The total cell number represents a sum of all cells 
tested during three to six repeats of independent experiments performed on different days.
Chemicals. All inorganic salts, phenylephrine, oxytocin, BSA, and DPBS were purchased from Sigma-Aldrich 
(St. Louis, MO, USA) and were of the highest purity. Penicillin and streptomycin were purchased from 
GIBCO-ThermoFisher Scientific (Gaithersburg, MD, USA). Prazosin and ICI118551 were purchased from 
Cayman Chemical (Ann Arbor, MI, USA).
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